MeSH D009059 - mouth diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009057:Stomatognathic diseases
0 Companies
0 Drugs
Success rate
D009059:Â
Mouth diseases
D001528:Behcet syndrome
D002054:Burning mouth syndrome
0 Companies
0 Drugs
Success rate
D002180:Oral candidiasis
D004368:Dry socket
0 Companies
0 Drugs
Success rate
D005150:Facial hemiatrophy
0 Companies
0 Drugs
Success rate
D005155:Facial nerve diseases
0 Companies
0 Drugs
Success rate
D005158:Facial paralysis
D006472:Oral hemorrhage
0 Companies
0 Drugs
Success rate
D007967:Oral leukoedema
0 Companies
0 Drugs
Success rate
D008047:Lip diseases
0 Companies
0 Drugs
Success rate
D008158:Ludwig's angina
0 Companies
0 Drugs
Success rate
D008556:Melkersson-rosenthal syndrome
0 Companies
0 Drugs
Success rate
D009056:Mouth abnormalities
0 Companies
0 Drugs
Success rate
D009062:Mouth neoplasms
0 Companies
0 Drugs
Success rate
D009066:Edentulous mouth
0 Companies
0 Drugs
Success rate
D009625:Noma
0 Companies
0 Drugs
Success rate
D009912:Oral manifestations
0 Companies
0 Drugs
Success rate
D009914:Oral submucous fibrosis
0 Companies
0 Drugs
Success rate
D010510:Periodontal diseases
D011900:Ranula
0 Companies
0 Drugs
Success rate
D012466:Salivary gland diseases
0 Companies
0 Drugs
Success rate
D013280:Stomatitis
D014060:Tongue diseases
0 Companies
0 Drugs
Success rate
D014393:Oral tuberculosis
0 Companies
0 Drugs
Success rate
D016155:Oral fistula
0 Companies
0 Drugs
Success rate
D017573:Focal epithelial hyperplasia
0 Companies
0 Drugs
Success rate
D017676:Oral lichen planus
0 Companies
0 Drugs
Success rate
D019226:Oral ulcer
D019569:Hemifacial spasm
0 Companies
0 Drugs
Success rate
D020330:Bell palsy
0 Companies
0 Drugs
Success rate
D051261:Orofacial granulomatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Lidocaine | Lidocaine |  | 1983-02-02 |  |  |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| Lidocaine | Lta |  | 1984-07-31 |  |  | |
| Afaxys | Lidocaine | Lidocaine |  | 2022-06-09 |  |  |
| Alembic Pharmaceuticals | Lidocaine | Lidocaine |  | 2018-11-23 |  |  |
| Lidocaine, Prilocaine | Lidocaine Prilocaine |  | 2022-04-08 |  |  | |
| Alkem Laboratories | Lidocaine | Lidocaine |  | 2017-03-10 |  |  |
| Allergan | Lidocaine | Lidocaine |  | 2011-03-23 |  |  |
| Lidocaine | Lidocaine Viscous |  | 1982-01-01 |  |  | |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| American Regent | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Amneal Pharmaceuticals | Lidocaine | Lidocaine |  | 2015-08-07 | $8.685 M | Y2017 |
| Amphastar Pharmaceuticals | Bupivacaine, Lidocaine | Duocaine |  | 2003-05-23 |  |  |
| APP Pharmaceuticals | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use